Optimizing cognitive and behavioural recovery after stroke: clinical integration of dietary supplements with a focus on ω-3 fatty acids
Neurochemistry International · 2026-11 · 106287
DOI: 10.1016/j.neuint.2026.106287 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemistry International, 2026-11. Verfasst von Anand Krishnan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cell Biology Laboratory, Centre for Development and Aging Research, Inter University Centre for Biomedical Research & Super Specialty Hospital, Mahat…. Die Arbeit nennt 537 Literaturangaben. Gefördert von: Department of Health Research.
Themen: Schlaganfall
Abstract (Originalsprache)
Stroke remains a leading cause of long-term disability worldwide, with many survivors experiencing persistent cognitive and behavioural impairments despite advancements in acute management. Post-stroke neurorecovery is often incomplete, contributing to dementia, depression, and reduced quality of life, particularly in low- and middle-income settings where access to advanced rehabilitation and therapeutics is limited. This highlights an urgent need for accessible, adjunctive strategies that can enhance functional recovery. Emerging preclinical evidence indicates that dietary supplements can modulate key biological processes underlying neurorecovery, including neuroplasticity, neuroinflammation, oxidative stress, mitochondrial function, and synaptic remodeling. In this narrative review, we examine the role of major classes of nutraceuticals such as omega-3 fatty acids, vitamins, minerals, polyphenols, and amino acids in supporting cognitive and behavioural recovery after stroke with particular emphasis on omega-3 fatty acids, given their central role in neuronal membrane integrity, lipid-mediated signaling, and resolution of inflammation. We integrate mechanistic insights with preclinical and clinical data explicitly highlighting that theoretical models and basic research demonstrate significant promise, while current clinical evidence remains heterogeneous and frequently inconclusive. We discuss how dietary supplementation might be strategically incorporated alongside conventional rehabilitation paradigms including physiotherapy cognitive training, and pharmacotherapy. We further highlight emerging concepts such as the gut-brain axis, precision nutrition, and biomarker-guided interventions, which are shaping the future of personalized neurorehabilitation. Ultimately, while dietary supplements offer a promising, cost-effective and accessible adjunctive approach, their current clinical utility is constrained by mixed translational efficacy. Overcoming these limitations will require rigorous patient selection, optimized timing and shift towards evidence-based personalized multimodal strategies. This will be essential to fully harness their therapeutic potential in improving cognitive and behavioural outcomes in stroke recovery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cell Biology Laboratory, Centre for Development and Aging Research, Inter University Centre for Biomedical Research & Super Specialty Hospital, Mahatma Gandhi University Campus at Thalappady, Rubber Board PO, Kottayam,…
- Department of Neurosurgery, Government Medical College and Hospital, Kottayam, Kerala, India.
- Aster Medcity Multispecialty Hospital, Kuttisahib Road Cheranelloor, South Chittoor, Kochi, Kerala, 682027, India.
- Genetics and Genomics Division, Centre for Development and Aging Research, Inter University Centre for Biomedical Research & Super Specialty Hospital, Mahatma Gandhi University Campus at Thalappady, Rubber Board PO, Kot…
- Centre for Drug Discovery, Inter University Centre for Biomedical Research & Super Specialty Hospital, Mahatma Gandhi University Campus at Thalappady, Rubber Board PO, Kottayam, 686009, Kerala, India.
- Lab of Translational Neuroscience, Yenepoya Research Centre, Yenepoya (Deemed to be University), University Road, Deralakatte, Mangalore, 575018, Karnataka, India.
Förderung
- Department of Health Research
Zitieren
APA
Krishnan, A., Saha, P., Aravind, M., Chandra Sreetama, S., Rajamma, U., Shenoi, R. A., Datta, A., & Chandra, G. (2026). Optimizing cognitive and behavioural recovery after stroke: clinical integration of dietary supplements with a focus on ω-3 fatty acids. Neurochemistry International, 106287. https://doi.org/10.1016/j.neuint.2026.106287
Vancouver
Krishnan A, Saha P, Aravind M, Chandra Sreetama S, Rajamma U, Shenoi RA, et al. Optimizing cognitive and behavioural recovery after stroke: clinical integration of dietary supplements with a focus on ω-3 fatty acids. Neurochemistry International. 2026:106287. doi:10.1016/j.neuint.2026.106287
BibTeX
@article{Krishnan2026,
author = {Krishnan, Anand and Saha, Prasanjit and Aravind, Manu and Chandra Sreetama, Sen and Rajamma, Usha and Shenoi, Rajesh Anantha and Datta, Arnab and Chandra, Goutam},
title = {Optimizing cognitive and behavioural recovery after stroke: clinical integration of dietary supplements with a focus on ω-3 fatty acids},
journal = {Neurochemistry International},
year = {2026},
pages = {106287},
doi = {10.1016/j.neuint.2026.106287}
}
EUVIMED